Rare Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You can be any age, from newborn to 100 years old, and any gender
- You have been diagnosed with a rare hereditary blood disorder (called a Rare Haematological Disease, or RHD) as listed in the ORPHANET classification system (confirm with trial site)
- You (or a parent/legal guardian if you are a minor) are willing and able to sign a consent form, as required by the laws in your country
Who may not be able to join:
- You will not be able to join if you only carry a genetic trait for a recessive rare hereditary blood disorder without having the full condition yourself (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: María del Mar Manú Pereira, PhD, Vall d'Hebron Institut de Recerca / University Hospital Vall d'Hebron (VHIR / HUVH)
Phone: +34934893000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Demography and epidemiology
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.